The influence of age on the pharmacokinetics of nimodipine

International Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 7, 1996, Pages 293-298

  Muck W ^a   Breuel, H P ^b   Kuhlmann, J ^a  

^a BAYER AG   (Germany)

^b Pharmacon Research   (Germany)

Author keywords

Age; Gender; Nimodipine; Pharmacokinetics

Indexed keywords

NIMODIPINE;

ADULT; AGE; AGED; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

ADULT; AGED; AGING; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; ELECTROCARDIOGRAPHY; FEMALE; HALF-LIFE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NIMODIPINE; SEX CHARACTERISTICS;

EID: 0030036378     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Baksi AK, Edwards JS, Ahr G 1991 A comparison of the pharmacokinetics of nisoldipine in elderly and young subjects. Br J Clin Pharmacol 31: 367-370
2. Blychert E, Edgar B, Elmfeldt D, Hedner T 1991 A population study of the pharmacokinetics of felodipine, Br J Clin Pharmacol 31: 15-24
3. Crome P, Flanagan RJ 1994 Pharmacokinetic studies in elderly people. Are they necessary? Clin Pharmacokinet 26: 243-247
4. Dawling S, Crome P 1989 Clinical pharmacokinetic considerations in the elderly - an update. Clin Pharmacokinet 17: 236-263
5. Durnas C, Loi CM, Cusack BJ 1990 Hepatic drug metabolism and aging. Clin Pharmacokinet 19: 359-389
6. Eicher H, Hilgert D, Zeeh J, Platt D, Becker C, Mutschler E 1992 Pharmacokinetics of nimodipine in multimorbid elderly patients with chronic brain failure. Arch Gerontol Geriatr 14: 309-319
7. FDA 1989 Guideline for the study of drugs likely to be used in the elderly. Rockville, MD, USA
8. Fitton A, Benfield P 1990 Isradipine - a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 40: 31-74
9. Garnier-Moiroux A, Henry JF, Taburet AM, Forette F, Singlas E 1987 Pharmacokinetics of nifedipine in the elderly. Therapie 42: 511- 514
10. Harten J van, Burggraaf J, Ligthart GJ, Brummelen P van, Breimer DD 1989 Single-dose and multiple-dose nisoldipine kinetics and effects in the young, middle-aged, and the elderly. Clin Pharmacol Ther 45: 600-607
11. Kendall MJ, Lobo J, Jack DB, Main AN 1987 The influence of age on the pharmacokinetics of nitrendipine. J Cardiovasc Pharmacol 9 (Suppl 4): 96-100
12. Langley MS, Sorkin EM 1989 Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in cerebrovascular disease. Drugs 37: 669-699
13. Lettieri J, Krol G, Yeh S, Ryan J, Jain A 1987 Pharmacokinetics of nitrendipine in elderly and young healthy volunteers. J Cardiovasc Pharmacol 9 (Suppl 4): 142-147
14. Mück W, Ahr G, Kuhlmann J 1995 Nimodipine - Potential for drug-drug interactions in the elderly. Drugs Aging 6: 229-242
15. Rämsch KD, Graefe KH, Scherling D, Sommer J, Ziegler R 1986 Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine, and nimodipine. Am J Nephrol 6 (Suppl 1): 73-80
16. Robertson DR, Waller DG, Renwick AG, George CF 1988 Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol 25: 297-305
17. Schall R, Müller FO, Groenewoud G, Mogilnicka EM, van Dyk M 1994 Single-dose and steady-state pharmacokinetic and pharmacodynamic profiles of nisoldipine coat-core tablets in healthy young, healthy elderly, and elderly hypertensive volunteers. Drug Invest 8: 21-30
18. Schmucker DL, Woodhouse KW, Wang RK, Wynne H, James OF, McManus M, Kremers P 1990 Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 48: 365-374
19. Vinge E, Andersson KE, Brandt L, Ljunggren B, Nilsson LG 1986 Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid hemorrhage. Eur J Clin Pharmacol 30: 421-425
20. Wadworth AN, McTavish D 1992 Nimodipine: a review of its pharmacological properties, and therapeutic efficacy in cerebral disorders. Drugs Aging 2: 262-286
21. Woodhouse KW, Wynne HA 1988 Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly. Clin Pharmacokinet 15: 287-294
22. Woodhouse K 1992 Drugs and the liver. Part III: Ageing of the liver and the metabolism of drugs. Biopharm Drug Dispos 13: 311-320
23. Wynne HA, Goudevenos J, Rawlins MD, James OFW, Adams PC, Woodhouse KW 1990 Hepatic drug clearance: the effect of age using indocyanine green as a model compound. Br J Clin Pharmacol 30: 634-637